OCUP · Categories · Form 4

OCUP - SEC Form 4 insider transactions

Ocuphire Pharma Inc. (OCUP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for OCUP

• 592d
  SEC Form 4 filed by Director Graves Adrienne L

  4 - Opus Genetics, Inc. (0001228627) (Issuer)
• 592d
  Director Bennett Jean was granted 100,000 shares (SEC Form 4)

  4 - Opus Genetics, Inc. (0001228627) (Issuer)
• 725d
  Director Rodgers Richard J was granted 41,143 shares, increasing direct ownership by 21% to 239,151 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 725d
  Director Pepose Jay was granted 41,143 shares, increasing direct ownership by 30% to 180,458 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 725d
  Director Manuso James S J was granted 41,143 shares, increasing direct ownership by 45% to 132,037 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 725d
  Director Gallagher Cam was granted 41,143 shares, increasing direct ownership by 115% to 77,047 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 725d
  Director Benton Susan was granted 41,143 shares, increasing direct ownership by 42% to 140,023 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 725d
  Director Ainsworth Sean was granted 41,143 shares, increasing direct ownership by 87% to 88,358 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 784d
  Pepose Jay was granted 32,000 shares, increasing direct ownership by 30% to 139,315 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 845d
  Jhaveri Nirav S. was granted 140,000 shares (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 845d
  Jayagopal Ashwath was granted 75,000 shares (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 868d
  Hoffmann Bernhard was granted 20,000 shares, increasing direct ownership by 14% to 162,697 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 868d
  Zaremba Rabourn Amy was granted 40,000 shares, increasing direct ownership by 94% to 82,658 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 878d
  Hoffmann Bernhard covered exercise/tax liability with 4,031 shares, decreasing direct ownership by 3% to 142,697 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 878d
  Zaremba Rabourn Amy covered exercise/tax liability with 3,950 shares, decreasing direct ownership by 8% to 42,658 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 878d
  Patel Ronil A. covered exercise/tax liability with 1,282 shares, decreasing direct ownership by 1% to 90,714 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 887d
  Pepose Jay was granted 14,964 shares, increasing direct ownership by 16% to 107,315 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 887d
  Manuso James S J was granted 22,090 shares, increasing direct ownership by 32% to 90,894 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 887d
  Rodgers Richard J was granted 24,762 shares, increasing direct ownership by 14% to 198,008 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 887d
  Benton Susan was granted 19,418 shares, increasing direct ownership by 24% to 98,880 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 916d
  Patel Ronil A. was granted 49,692 shares, increasing direct ownership by 117% to 91,996 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 924d
  SEC Form 4 filed by Schachle Joseph K

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 938d
  Pepose Jay was granted 35,000 shares, increasing direct ownership by 61% to 92,351 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 938d
  Rodgers Richard J was granted 35,000 shares, increasing direct ownership by 25% to 173,246 units (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 949d
  Magrath George was granted 400,000 shares (SEC Form 4)

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1096d
  SEC Form 4 filed by Manuso James S J

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1096d
  SEC Form 4 filed by Ainsworth Sean

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1096d
  SEC Form 4 filed by Pepose Jay

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1096d
  SEC Form 4 filed by Gallagher Cam

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1096d
  SEC Form 4 filed by Benton Susan

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1139d
  SEC Form 4 filed by Patel Ronil A.

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1144d
  SEC Form 4 filed by Benton Susan

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1144d
  SEC Form 4 filed by Manuso James S J

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1144d
  SEC Form 4 filed by Pepose Jay

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1144d
  SEC Form 4 filed by Rodgers Richard J

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1243d
  SEC Form 4: Sooch Mina was granted 134,456 shares, increasing direct ownership by 45% to 430,501 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1243d
  SEC Form 4: Manuso James S J was granted 18,544 shares, increasing direct ownership by 51% to 55,009 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1243d
  SEC Form 4: Pepose Jay was granted 13,013 shares, increasing direct ownership by 40% to 45,907 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1243d
  SEC Form 4: Rodgers Richard J was granted 20,822 shares, increasing direct ownership by 31% to 88,246 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1243d
  SEC Form 4: Hoffmann Bernhard was granted 46,608 shares, increasing direct ownership by 47% to 146,728 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1243d
  SEC Form 4: Zaremba Rabourn Amy was granted 46,608 shares

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1243d
  SEC Form 4: Benton Susan was granted 16,267 shares, increasing direct ownership by 32% to 67,433 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1250d
  SEC Form 4: Gallagher Cam exercised 1,574 in-the-money shares at a strike of $0.00, increasing direct ownership by 7% to 24,928 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1327d
  SEC Form 4: Ainsworth Sean exercised 1,574 in-the-money shares at a strike of $0.00, increasing direct ownership by 4% to 41,239 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1335d
  SEC Form 4: Manuso James S J exercised 787 in-the-money shares at a strike of $0.00, increasing direct ownership by 2% to 36,465 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1344d
  SEC Form 4: Rodgers Richard J exercised 3,148 in-the-money shares at a strike of $0.00, increasing direct ownership by 5% to 67,424 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1369d
  SEC Form 4: Sooch Mina exercised 1,023 in-the-money shares at a strike of $0.00, increasing direct ownership by 0.24% to 426,045 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1433d
  SEC Form 4: Benton Susan was granted 18,711 shares, increasing direct ownership by 58% to 51,166 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1433d
  SEC Form 4: Rodgers Richard J was granted 23,653 shares, increasing direct ownership by 58% to 64,276 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1433d
  SEC Form 4: Manuso James S J was granted 14,108 shares, increasing direct ownership by 65% to 35,678 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1433d
  SEC Form 4: Pepose Jay was granted 9,900 shares, increasing direct ownership by 43% to 32,894 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1454d
  SEC Form 4 filed by Benton Susan

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1454d
  SEC Form 4 filed by Rodgers Richard J

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1454d
  SEC Form 4 filed by Pepose Jay

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1454d
  SEC Form 4 filed by Manuso James S J

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1454d
  SEC Form 4 filed by Gallagher Cam

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1454d
  SEC Form 4 filed by Ainsworth Sean

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1477d
  SEC Form 4: Manuso James S J bought $9,950 worth of shares (5,000 units at $1.99), increasing direct ownership by 30% to 21,570 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1477d
  SEC Form 4: Sooch Mina bought $51,179 worth of shares (25,000 units at $2.05), increasing direct ownership by 6% to 425,022 units

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)
• 1517d
  SEC Form 4 filed by Pepose Jay

  4 - Ocuphire Pharma, Inc. (0001228627) (Issuer)

Other OCUP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends